Clinical Trial Update: A Single Dose Study of the CAM-3001 in Patients With Rheumatoid Arthritis [Phase 1]

View source ↗

Summary

Reports a Phase 1, single-dose study of CAM-3001 in patients with rheumatoid arthritis. The trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• CAM-3001

Snippet

Sponsor: MedImmune Ltd | Conditions: Rheumatoid Arthritis | Phase 1 | Status: COMPLETED